218 related articles for article (PubMed ID: 18006755)
1. Defining cancer cachexia in head and neck squamous cell carcinoma.
Richey LM; George JR; Couch ME; Kanapkey BK; Yin X; Cannon T; Stewart PW; Weissler MC; Shores CG
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6561-7. PubMed ID: 18006755
[TBL] [Abstract][Full Text] [Related]
2. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
3. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
5. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
6. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens.
Woods KV; El-Naggar A; Clayman GL; Grimm EA
Cancer Res; 1998 Jul; 58(14):3132-41. PubMed ID: 9679981
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-18 in patients with head and neck squamous cell carcinoma.
Riedel F; Adam S; Feick P; Haas S; Götte K; Hörmann K;
Int J Mol Med; 2004 Feb; 13(2):267-72. PubMed ID: 14719133
[TBL] [Abstract][Full Text] [Related]
8. Elevation of cytokine levels in cachectic patients with prostate carcinoma.
Pfitzenmaier J; Vessella R; Higano CS; Noteboom JL; Wallace D; Corey E
Cancer; 2003 Mar; 97(5):1211-6. PubMed ID: 12599227
[TBL] [Abstract][Full Text] [Related]
9. Comparison of animal models for head and neck cancer cachexia.
Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
[TBL] [Abstract][Full Text] [Related]
10. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
[TBL] [Abstract][Full Text] [Related]
11. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients.
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Blachut K; Kustrzeba-Wojcicka I; Banas T
Clin Biochem; 2007 Dec; 40(18):1353-60. PubMed ID: 17931612
[TBL] [Abstract][Full Text] [Related]
12. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.
Lathers DM; Young MR
Cytokine; 2004 Mar; 25(5):220-8. PubMed ID: 15036248
[TBL] [Abstract][Full Text] [Related]
13. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
[TBL] [Abstract][Full Text] [Related]
14. Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia.
Rydén M; Agustsson T; Laurencikiene J; Britton T; Sjölin E; Isaksson B; Permert J; Arner P
Cancer; 2008 Oct; 113(7):1695-704. PubMed ID: 18704987
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
16. Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness.
Douglas WG; Tracy E; Tan D; Yu J; Hicks WL; Rigual NR; Loree TR; Wang Y; Baumann H
Mol Cancer Res; 2004 Oct; 2(10):585-93. PubMed ID: 15498933
[TBL] [Abstract][Full Text] [Related]
17. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
[TBL] [Abstract][Full Text] [Related]
18. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.
O'Regan EM; Toner ME; Finn SP; Fan CY; Ring M; Hagmar B; Timon C; Smyth P; Cahill S; Flavin R; Sheils OM; O'Leary JJ
Hum Pathol; 2008 Mar; 39(3):452-8. PubMed ID: 18261630
[TBL] [Abstract][Full Text] [Related]
19. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
